NR1I3 and metabolic syndrome: Taken together, the nexus of PPARα (albeit weakly activated in humans; Takacs and Abbott (2007)), CAR, and PXR activations under PFOS exposure implicate dysregulations of energy homeostasis (particularly dyslipidemia) and consequent widespread adverse physiological effects.